𝔖 Bobbio Scriptorium

✦ LIBER ✦

Elevated Nt-proANP in Type 2 Diabetes without Heart Failure, Is a Marker for Coronary and Peripheral Artery Disease

✍ Scribed by Michel P. Hermans; Sylvie A. Ahn; Damien Gruson; Jean-Marie Ketelslegers; Michel F. Rousseau

Book ID: 119213820
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 83 KB
Volume: 12
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2006.06.124

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased urinary albumin excretion is a

Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus

✍ Michele Lunetta; Lorena Infantone; Aldo E Calogero; Enrico Infantone 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 177 KB

To: Wannamethee SG, Lowe GDO, Shaper AG,

To: Wannamethee SG, Lowe GDO, Shaper AG, Rumley A, Lennon L, Whincup PH (2004) Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Diabetologia 47:1557–1565

✍ F. L. Fimognari; R. Pastorelli; R. A. Incalzi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 55 KB

The risk of developing coronary artery d

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

✍ Kevin M. Pantalone; Michael W. Kattan; Changhong Yu; Brian J. Wells; Susana Arri 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 286 KB

Reply to Comment on: Wannamethee SG, Low

Reply to Comment on: Wannamethee SG, Lowe GDO, Shaper AG, Rumley A, Lennon L, Whincup PH (2004) Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Diabetologia 47:1557–1565

✍ S. G. Wannamethee; A. G. Shaper; P. H. Whincup 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 46 KB

Pantalone et al.: The risk of developing

Pantalone et al.: The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

✍ David S. H. Bell 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 75 KB

Letter to the Editor re: the Letter to t

Letter to the Editor re: the Letter to the Editor by Dr. David Samuel Henry Bell, MD regarding “The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis”

✍ Robert S. Zimmerman; Kevin Matthew Pantalone 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 82 KB